![]() |
|
|
|
Assay DevelopmentWhen change is the norm Timely access to assay development capabilities can often be a critical factor in ensuring compound throughput in screening. Managing the process of defining and validating assays ready for production requires not only ready access to resources and staff but also accessibility to historical data. Access to validation and robustness data is often limited to spreadsheets located on individual's computers. Ready access to assay development data can be critical to the smooth transition of an assay into production and to maintaining assay stability over time. Traditional solutions used to manage data from HTS are not flexible enough to be used in assay development. They require too much effort to maintain and rely on high levels of IT support. MorphIt and BioRails provide the ideal combination of flexibility and structure allowing knowledge from assay development to be accessed together with all of the data from the discovery value chain.
|
27 November 2008 Get the latest information05 October 2008 BioRails Boot Camp 2008The first training boot camp will be held 6th - 9th October. Attendees will recieve comprehensive training on the latest data management techniques using BioRails. If you're interested in attending a future training camp please contact us. 25 September 2008 Exhibition at Drug Discovery 2008Located in the innovation zone at this busy meeting, The Edge joined a number of emerging new companies displaying a range of new innovative solutions challenging the dominance of more established players in the market. 05 August 2008 Team ExpandingIn response to an increased demand for our services and software we've vacancies to expand the team. 22 June 2008 The Edge release cheminformatics nodes4knimeThe first release of cheminformatics nodes for the knime platform have been released. 21 November 2007 Lundbeck Pharmaceuticals select BioRails as the biologist's ELNBioRails will be deployed globally to support all biological research.
|
|
|
|||||||||||||
|
|
|
|
|||||||||||
|
|
|||||||||||||